Benefaction of probiotics for human health: A review

Rout George Kerry, Jayanta Kumar Patra, Sushanto Gouda, Yooheon Park, Han-Seung Shin, Gitishree Das, Rout George Kerry, Jayanta Kumar Patra, Sushanto Gouda, Yooheon Park, Han-Seung Shin, Gitishree Das

Abstract

Humans are a unique reservoir of heterogeneous and vivacious group of microbes, which together forms the human-microbiome superorganism. Human gut serves as a home to over 100-1000 microbial species, which primarily modulate the host internal environment and thereby, play a major role in host health. This spectacular symbiotic relationship has attracted extensive research in this field. More specifically, these organisms play key roles in defense function, eupepsia along with catabolism and anabolism, and impact brain-gut responses. The emergence of microbiota with resistance and tolerance to existing conventional drugs and antibiotics has decreased the drug efficacies. Furthermore, the modern biotechnology mediated nano-encapsulated multiplex supplements appear to be high cost and inconvenient. Henceforth, a simple, low-cost, receptive and intrinsic approach to achieve health benefits is vital in the present era. Supplementation with probiotics, prebiotics, and synbiotics has shown promising results against various enteric pathogens due to their unique ability to compete with pathogenic microbiota for adhesion sites, to alienate pathogens or to stimulate, modulate and regulate the host's immune response by initiating the activation of specific genes in and outside the host intestinal tract. Probiotics have also been shown to regulate fat storage and stimulate intestinal angiogenesis. Hence, this study aims to underline the possible beneficial impact of probiotics for human health and medical sectors and for better lifestyle.

Keywords: Human-gut; Microbiota; Pathogenic; Probiotics; Symbiotic relationship.

Conflict of interest statement

Conflict of interest

Author declares no conflict of interest.

Copyright © 2018. Published by Elsevier B.V.

Figures

Fig. 1
Fig. 1
Different sources of probiotics.
Fig. 2
Fig. 2
Applications of probiotics and their mode of action.

References

    1. Bagchi T. Traditional food & modern lifestyle: impact of probiotics. Indian J Med Res. 2014;140(3):333–5.
    1. Metchnikoff E, Mitchell PC, editors. Essais optimistes. London: Heinemann; 1907.
    1. Tissier H. Tritement des infections intestinales par la methode de translormation de la flore bacterienne de lintestin. C R Soc Biol. 1906;60:359–61. [in French]
    1. Havenaar R, Huis in’t Veld JHJ. Probiotics: a general view. In: Wood BJB, editor. The lactic acid bacteria in health and disease. London: Elsevier Applied Science; 1992. pp. 151–70.
    1. Aziz Q, Dore J, Emmanuel A, Guarners F, Quigley EMM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neuro Gastroenterol Motil. 2013;25:4–15.
    1. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5:1417–35.
    1. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8:1–11.
    1. Lewis BB, Buffie CG, Carter R, Leiner I, Toussaint NC, Miller L, et al. Loss of microbiota-mediated colonization resistance to clostridium difficile infection is greater following oral vancomycin as compared with metronidazole. J Infect Dis. 2015;212:1656–65.
    1. Perez-Cobas AE, Moya A, Gosalbes MJ, Latorre A. Colonization resistance of the gut microbiota against clostridium difficile. Antibiotics. 2015;4:337–57.
    1. Scott KP, Antoine J-M, Midtvedt T, van Hemert S. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis. 2015:26. doi: 10.3402/mehd.v26.25877.
    1. Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016;352:535–8.
    1. Qadir MI. Phage therapy: a modern tool to control bacterial infections. Pak J Pharm Sci. 2015;28:265–70.
    1. Rao SC, Athalye-Jape GK, Deshpande GC, Simmer KN, Patole SK. Probiotic supplementation and late-onset sepsis in preterm infants: a meta-analysis. Pediatrics. 2016;137:1–16.
    1. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016;8:1–11.
    1. Bakirtzi K, Law IKM, Xue X, Iliopoulos D, Shah YM, Pothoulakis C. Neurotensin promotes the development of colitis and intestinal angiogenesis via Hif-1α–miR-210 signaling. J Immunol. 2016;196:4311–21.
    1. Chen X, Yang G, Song J-H, Xu H, Li D, Goldsmith J, et al. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. PLoS One. 2013;8:1–7.
    1. Kobyliak N, Conte C, Cammarota G, Haley AP, Styriak I, Gaspar L, et al. Probiotics in prevention and treatment of obesity: a critical view. Nutr Metab. 2016;13:1–13.
    1. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401–12.
    1. Hamasalim HJ. Synbiotic as feed additives relating to animal health and performance. Adv Microbiol. 2016;6:288–302.
    1. Bongaerts GPA, Severijnen RSVM. A reassessment of the PROPATRIA study and its implications for probiotic therapy. Nature Biotechnol. 2016;34:55–63.
    1. Patel RM, Denning PW. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence? Clin Perinatol. 2013;40:11–25.
    1. Islam SU. Clinical uses of probiotics. Medicine (Baltimore) 2016;95:1–5.
    1. Ooi MF, Mazlan N, Foo HL, Loh TC, Mohamad R, Rahim RA, et al. Effects of carbon and nitrogen sources on bacteriocin-inhibitory activity of postbiotic metabolites produced by Lactobacillus plantarum I-UL4. Malays J Microbiol. 2015;11:176–84.
    1. Giorgetti GM, Brandimarte G, Fabiocchi F, Ricci S, Flamini P, Sandri G, et al. Interactions between innate immunity, microbiota, and probiotics. J Immunol Res. 2015;501361:7.
    1. Cicenia A, Scirocco A, Carabotti M, Pallotta L, Marignani M, Severi C. Postbiotic activities of lactobacilli-derived factors. J Clin Gastroenterol. 2014;48:S18–22.
    1. Rastall RA, Gibson GR. Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr Opinion Biotechnol. 2015;32:42–6.
    1. Thomas LV. Probiotics-the journey continues. Int J Dairy Tech. 2016;69:1–12.
    1. Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G, Goh YJ, et al. Prebiotics: why definitions matter. Curr Opin Biotechnol. 2016;37:1–13.
    1. Tanaka R, Takayama H, Morotomi M, Kuroshima T, Ueyama S, Matsumoto K, et al. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobact Microflora. 1983;2:17–24.
    1. Pena AS. Intestinal flora, probiotics, prebiotics, synbiotics and novel foods. Rev Esp Enferm Dig. 2007;99:653–8.
    1. Pokusaeva K, Fitzgerald GF, Sinderen D. Carbohydrate metabolism in bifidobacteria. Genes Nutr. 2011;6:285–306.
    1. Tufarelli V, Laudadio V. An overview on the functional food concept: prospectives and applied researches in probiotics, prebiotics and synbiotics. J Exp Biol Agric Sci. 2016;4:274–8.
    1. Tejero-Sarinena S, Barlow J, Costabile A, Gibson GR, Rowland I. Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains? Anaerobe. 2013;24:60–5.
    1. Kareem KY, Ling FH, Chwen LT, Foong OM, Asmara SA. Inhibitory activity of postbiotic produced by strains of Lactobacillus plantarum using reconstituted media supplemented with inulin. Gut Pathog. 2014;6:1–7.
    1. Simova ED, Beshkova DB, Dimitrov P. Characterization and antimicrobial spectrum of bacteriocins produced by lactic acid bacteria isolated from traditional Bulgarian dairy products. J Appl Microbiol. 2009;106:692–701.
    1. Ammor S, Tauveron G, Dufour E, Chevallier I. Antibacterial activity of lactic acid bacteria against spoilage and pathogenic bacteria isolated from the same meat small-scale facility. Screening and characterization of the antibacterial compounds. Food Control. 2006;17:454–61.
    1. Figueroa-Gonzalez I, Cruz-Guerrero A, Quijano G. The benefits of probiotics on human health. J Microb Biochem Technol. 2011;S1:003.
    1. Waigankar SS, Patel V. Role of probiotics in urogenital healthcare. J Midlife Health. 2011;2:5–10.
    1. Hanson L, Vusse LV, Jerme M, Abad CL, Safdar N. Probiotics for treatment and prevention of urogenital infections in women: a systematic review. J Midwifery Womens Health. 2016;61:339–55.
    1. Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, et al. Extra genital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol. 2016;5758387:17.
    1. International Diabetes Federation. Diabetes atlas. Chausséede la Hulpe 166, 1170. Watermael-Boitsfort, Belgium: IDF Diabetes Atlas; 2017. [Accessed 15 November 2017]. .
    1. Iqbal MZ, Qadir MI, Hussain T, Janbaz KH, Khan YH, Ahmad B. Probiotics and their beneficial effects against various diseases. Pak J Pharm Sci. 2014;27:405–15.
    1. Larsen N, Vogensen FK, van-den-Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5:1–10.
    1. Barz ML, Anhe FF, Varin TV, Desjardins Y, Levy E, Roy D, et al. Probiotics as complementary treatment for metabolic disorders. Diabetes Metab J. 2015;39:291–303.
    1. Barrett HL, Callaway LK, Nitert MD. Probiotics: a potential role in the prevention of gestational diabetes? Acta Diabetol. 2012;49:1–13.
    1. Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012a;113:411–7.
    1. Hu C, Wong FS, Wen L. Type 1 diabetes and gut microbiota: friend or foe? Pharmacol Res. 2015;98:9–15.
    1. Ljungberg M, Korpela R, Ilonen J, Ludvigsson J, Vaarala O. Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type-1 diabetes-the PRODIA study. Ann N Y Acad Sci. 2006;1079:360–4.
    1. Hartstra AV, Bouter KEC, Backhed F, Nieuwdorp M. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care. 2015;38:159–65.
    1. Grover S, Rashmi HM, Srivastava AK, Batish VK. Probiotics for human health-new innovations and emerging trends. Gut Pathog. 2012;4:1–14.
    1. Karimi G, Sabran MR, Jamaluddin R, Parvaneh K, Mohtarrudin N, Ahmad Z, et al. The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats. Food Nutr Res. 2015;59:1–8.
    1. Kang J-H, Yun S-I, Park M-H, Park J-H, Jeong S-Y, Park H-O. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One. 2013;8:1–8.
    1. Palumbo VD, Marcello R, Gammazza AM, Carini F, Damiani P, Damiano G, et al. The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study. Biomed Pap. 2016;160:372–7.
    1. Cammarota G, Ianiro G, Cianci R, Bibbo S, Gasbarrini A, Curro D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacol Ther. 2015;149:191–212.
    1. Cammarota G, Pecere S, Ianiro G, Masucci L, Curro D. Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases. Dig Dis. 2016;34:279–85.
    1. Spiller R. Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Research. 2016;5:1–11.
    1. Curro D, Ianiro G, Pecere S, Bibbo S, Cammarota G. Probiotics, fiber and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol. 2016;173:61–8.
    1. Shahverdi E. Probiotics and gastrointestinal diseases. Int J Dig Dis. 2016;2:1–2.
    1. Gowri RS, Meenambigai P, Prabhavathi P, Rajeswari PR, Yesudoss LA. Probiotics and its effects on human health-a review. Int J Curr Microbiol Appl Sci. 2016;5:384–92.
    1. World Health Organization. Cancer fact sheet 2017. Switzerland: World Health Organization; 2017.
    1. Vidya S, Thiruneelakandan G. Probiotic potentials of lactobacillus and its anti-cancer activity. Int J Curr Res. 2015;7:20680–4.
    1. Gayathri D, Rashmi BS. Anti-cancer properties of probiotics: a natural strategy for cancer prevention. EC Nutrition. 2016;5:1191–202.
    1. Vafaeie F. Critical review on probiotics and its effect on cancer. Vol. 2. Cancer Press; 2016. pp. 30–4.
    1. So SS, Wan ML, El-Nezami H. Probiotics-mediated suppression of cancer. Curr Opinion Oncol. 2017;29:62–72.
    1. Kahouli I, Malhotra M, Alaoui-Jamali MA, Prakash S. In-vitro characterization of the anti-cancer activity of the probiotic bacterium Lactobacillus fermentum NCIMB 5221 and potential against colorectal cancer cells. J Cancer Sci Ther. 2015;7:224–35.
    1. Awaisheh SS, Obeidat MM, Al-Tamimi HJ, Assaf AM, EL-Qudah JM, Al-khazaleh JM, et al. In vitro cytotoxic activity of probiotic bacterial cell extracts against Caco-2 and HRT-18 colorectal cancer cells. Milk Sci Int. 2016;69:27–31.
    1. Akelma AZ, Topcu ZIK. Probiotics and allergic disease. World J Immunol. 2016;6I:75–82.
    1. Song S, Lee SJ, Park D-J, Oh S, Lim K-T. The anti-allergic activity of Lactobacillus plantarum L67 and its application to yogurt. J Dairy Res. 2016;99:9372–82.
    1. Takeda S, Hidaka M, Yoshida H, Takeshita M, Kikuchi Y, Tsend-Ayush C, et al. Antiallergic activity of probiotics from Mongolian dairy products on type I allergy in mice and mode of antiallergic action. J Funct Foods. 2014;9:60–9.
    1. Flkman J. Angiogenesis. Annu Rev Med. 2006;57:1–18.
    1. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6:273–86.
    1. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015;125:926–38.
    1. Tillisch K. The effects of gut microbiota on CNS function in humans. Gut Microbes. 2014;5:404–10.
    1. Umbrello G, Esposito S. Microbiota and neurologic diseases: potential effects of probiotics. J Transl Med. 2016;14:1–11.
    1. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105:755–64.
    1. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009;1:1–6.
    1. Szajewska H. What are the indications for using probiotics in children? Arch Dis Child. 2016;101:398–403.
    1. Daliri EBM, Oh DH, Lee BH. Psychobiotics; a promise for neurodevelopmental therapy. J Probiotics Health. 2016;4:1–4.
    1. Nogueiras R, Romero-Pico A, Vazquez MJ, Novelle MG, Lopez M. The opioid system and food intake: homeostatic and hedonic mechanisms. Obes Facts. 2012;5:196–207.
    1. Kelly G. Inulin-type prebiotics – a review: Part 1. Altern Med Rev. 2008;13(4):315–29.
    1. Moreno FJ, Corzo N, Montilla A, Villamiel M, Olano A. Current state and latest advances in the concept, production and functionality of prebiotic oligosaccharides. Curr Opin Food Sci. 2017;13:50–5.
    1. Villamiel M, Montilla A, Olano A, Corzo N. Production and bioactivity of oligosaccharides derived from lactose. In: Moreno FJ, Sanz ML, editors. Food oligosaccharides: production, analysis and bioactivity. Wiley Blackwell; 2014. pp. 137–67.
    1. Trollope KM, van Wyk N, Kotjomela MA, Volschenk H. Sequence and structure-based prediction of fructosyltransferase activity for functional sub classification of fungal GH32 enzymes. FEBS J. 2015;282:4782–96.
    1. Devlamynck T, Te Poele EM, Meng X, van Leeuwen SS, Dijkhuizen L. Glucansucrase Gtf180-DN of Lactobacillus reuteri 180: enzyme and reaction engineering for improved glycosylation of non-carbohydrate molecules. Appl Microbiol Biotechnol. 2016;100:7529–39.
    1. Schmid J, Heider D, Wendel NJ, Sperl N, Sieber V. Bacterial glycosyltransferases: challenges and opportunities of a highly diverse enzyme class toward tailoring natural products. Front Microbiol. 2016;7:182.
    1. FDA. GRAS notice (GRN) No. 571. 20–Fucosyllactose. 2015. .
    1. Collins S, Reid G. Distant site effects of ingested prebiotics. Nutrients. 2016;8:523.
    1. Zhou Y, Kruger C, Ravi GS, Kumar DPS, Vijayasarathi SK, Lavingia M, et al. Safety evaluation of galactooligosaccharides: sub chronic oral toxicity study in Sprague-Dawley rats. Toxicol Res Appl. 2017;1:1–12.
    1. Savignac HM, Corona G, Mills H, Chen L, Spencer JP, Tzortzis G, et al. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine. Neurochem Int. 2013;63:756–64.
    1. Williams S, Chen L, Savignac HM, Tzortzis G, Anthony DC, Burnet PW. Neonatal prebiotic (BGOS) supplementation increases the levels of synaptophysin, GluN2A-subunits and BDNF proteins in the adult rat hippocampus. Synapse. 2016;70:121–4.
    1. Pretorius R, Prescott SL, Palmer DJ. Taking a prebiotic approach to early immunomodulation for allergy prevention. Expert Rev Clin Immunol. 2018;14(1):43–51.
    1. Hong KB, Jeong M, Han KS, Kim JH, Park Y, Suh HJ. Photoprotective effects of galacto-oligosaccharide and/or Bifidobacterium longum supplementation against skin damage induced by ultraviolet irradiation in hairless mice. Int J Food Sci Nutr. 2015;66:923–30.
    1. Gibson GR, Hutkins R, Sanders ML, Prescott SL, Reimer RA, Salminen SJ, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491–502.
    1. Kano M, Masuoka N, Kaga C, Sugimoto S, Iizuka R, Manabe K, et al. Consecutive intake of fermented milk containing Bifidobacterium breve strain Yakult and galacto-oligosaccharides benefits skin condition in healthy adult women. Biosci Microbiota Food Health. 2013;32:33–9.
    1. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104(2):S1–63.
    1. Yoo JY, Kim SS. Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients. 2016;8(3):173.
    1. Dixit Y, Wagle A, Vakil B. Patents in the field of probiotics, prebiotics, synbiotics: a review. J Food Microbiol Saf Hygiene. 2016;1:1–13.
    1. Nguyen H-T, Truong D-H, Kouhounde S, Ly S, Razafindralambo H, Delvigne F. Biochemical engineering approaches for increasing viability and functionality of probiotic bacteria. Int J Mol Sci. 2016;17:1–18.
    1. Eid R, Jakee JE, Rashidy A, Asfour H, Omara S, Kandil MM, et al. Potential antimicrobial activities of probiotic Lactobacillus strains isolated from raw milk. J Probiotics Health. 2016;4:1–8.
    1. Onyenweaku F, Obeagu EI, Ifediora AC, Nwandikor UU. Health benefits of probiotics. Int J Innov Appl Res. 2016;4:21–30.
    1. Sornplang P, Piyadeatsoontorn S. Probiotic isolates from unconventional sources: a review. J Anim Sci Tech. 2016;58:1–11.
    1. Arora T, Singh S, Sharma RK. Probiotics: interaction with gut microbiome and antiobesity potential. Nutrition. 2013;29:591–6.
    1. Westermann C, Gleinser M, Corr SC, Riedel CU. A critical evaluation of Bifidobacterial adhesion to the host tissue. Front Microbiol. 2016;7:1–8.
    1. Tsilingiri K, Rescigno M. Postbiotics: what else? Benef Microbes. 2012;4:101–7.
    1. Zagato E, Mileti E, Massimiliano L, Fasano F, Budelli A, Penna G, et al. Lactobacillus paracasei CBA L74 metabolic products and fermented milk for infant formula have anti-inflammatory activity on dendritic cells in vitro and protective effects against colitis and an enteric pathogen in vivo. PLoS One. 2014;9:1–14.
    1. Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V, Aindelis G, Tompoulidou E, Lamprianidou EE, et al. Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS One. 2016;11:1–20.
    1. Sabater-Molina M, Larque E, Torrella F, Zamora S. Dietary fructo-oligosaccharides and potential benefits on health. J Physiol Biochem. 2009;65:315–28.
    1. Patel S, Goyal A. The current trends and future perspectives of prebiotics research: a review. 3 Biotech. 2012;2:115–25.
    1. Oliveira RPDS, Florence ACR, Perego P, De Oliveira MN, Converti A. Use of lactulose as prebiotic and its influence on the growth, acidification profile and viable counts of different probiotics in fermented skim milk. Int J Food Microbiol. 2011;145:22–7.
    1. Zhou X, Ruan Z, Huang X, Zhou Y, Liu S, Yin Y. The prebiotic lactosucrose modulates gut metabolites and microbiota in intestinal inflammatory rats. Food Sci Biotechnol. 2014;23:157–63.
    1. Torres DPM, Goncalves MPF, Teixeira JA, Rodrigues LR. Galacto-oligosaccharides: production, properties, applications, and significance as prebiotics. Compr Rev Food Sci Food Saf. 2010;9:438–54.
    1. Rycroft CE, Jones MR, Gibson GR, Rastall RA. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol. 2001;91:878–87.
    1. Aachary AA, Prapulla SG. Xylooligosaccharides (XOS) as an emerging prebiotic: microbial synthesis, utilization, structural characterization, bioactive properties, and applications. Compr Rev Food Sci Food Saf. 2011;10:1–16.
    1. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91:814–9.
    1. Fuentes-Zaragoza E, Sanchez-Zapata E, Sendra E, Sayas E, Navarro C, Fernandez-Lopez J, et al. Resistant starch as prebiotic: a review. Starch Starke. 2011;63:406–15.
    1. Hoseinifar SH, Ahmadi A, Raeisi M, Hoseini SH, Khalili M, Behnampour N. Comparative study on immunomodulatory and growth enhancing effects of three prebiotics (galactooligosaccharide, fructooligosaccharide and inulin) in common carp (Cyprinus carpio) Fish Shellfish Immunol. 2016;58:1–10.
    1. Han W-C, Byun S-H, Kim M-H, Sohn EH, Lim JD, Um BH, et al. Production of lactosucrose from sucrose and lactose by a levansucrase from Zymomonas mobilis. J Microbiol Biotechnol. 2009;19:1153–60.
    1. Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol. 2008;104:305–44.
    1. Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis. 2005;40:28–37.
    1. Bird AR, Brown IL, Topping DL. Starches, resistant starches, the gut microflora and human health. Curr Issues Intest Microbiol. 2000;1:25–37.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj